nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—enteric nervous system—ulcerative colitis	0.0183	0.356	CbGeAlD
Zuclopenthixol—HTR2A—myenteric nerve plexus—ulcerative colitis	0.0138	0.27	CbGeAlD
Zuclopenthixol—Fluphenazine—CALM3—ulcerative colitis	0.00422	0.201	CrCbGaD
Zuclopenthixol—DRD5—lymphoid tissue—ulcerative colitis	0.00356	0.0694	CbGeAlD
Zuclopenthixol—Trifluoperazine—CALM3—ulcerative colitis	0.00337	0.161	CrCbGaD
Zuclopenthixol—Perphenazine—CALM3—ulcerative colitis	0.00333	0.159	CrCbGaD
Zuclopenthixol—Chlorpromazine—CALM3—ulcerative colitis	0.00265	0.126	CrCbGaD
Zuclopenthixol—ADRA1A—epithelium—ulcerative colitis	0.00213	0.0415	CbGeAlD
Zuclopenthixol—HRH1—epithelium—ulcerative colitis	0.00165	0.0321	CbGeAlD
Zuclopenthixol—ADRA1A—lymphoid tissue—ulcerative colitis	0.00164	0.032	CbGeAlD
Zuclopenthixol—HRH1—smooth muscle tissue—ulcerative colitis	0.00159	0.031	CbGeAlD
Zuclopenthixol—HTR2A—epithelium—ulcerative colitis	0.00138	0.0268	CbGeAlD
Zuclopenthixol—HTR2A—smooth muscle tissue—ulcerative colitis	0.00133	0.0259	CbGeAlD
Zuclopenthixol—HRH1—digestive system—ulcerative colitis	0.00126	0.0244	CbGeAlD
Zuclopenthixol—ADRA1A—liver—ulcerative colitis	0.00121	0.0235	CbGeAlD
Zuclopenthixol—Flupentixol—ABCB1—ulcerative colitis	0.00112	0.0537	CrCbGaD
Zuclopenthixol—HTR2A—digestive system—ulcerative colitis	0.00105	0.0204	CbGeAlD
Zuclopenthixol—CYP2D6—digestive system—ulcerative colitis	0.000955	0.0186	CbGeAlD
Zuclopenthixol—HTR2A—liver—ulcerative colitis	0.000781	0.0152	CbGeAlD
Zuclopenthixol—Domperidone—ABCB1—ulcerative colitis	0.000757	0.0361	CrCbGaD
Zuclopenthixol—CYP2D6—liver—ulcerative colitis	0.000711	0.0139	CbGeAlD
Zuclopenthixol—Nefazodone—ABCB1—ulcerative colitis	0.000628	0.03	CrCbGaD
Zuclopenthixol—Trazodone—ABCB1—ulcerative colitis	0.000581	0.0278	CrCbGaD
Zuclopenthixol—Thioproperazine—ALB—ulcerative colitis	0.00058	0.0277	CrCbGaD
Zuclopenthixol—Vertigo—Methylprednisolone—ulcerative colitis	0.000574	0.000766	CcSEcCtD
Zuclopenthixol—Syncope—Methylprednisolone—ulcerative colitis	0.000573	0.000765	CcSEcCtD
Zuclopenthixol—Discomfort—Hydrocortisone—ulcerative colitis	0.000572	0.000763	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Prednisone—ulcerative colitis	0.000571	0.000762	CcSEcCtD
Zuclopenthixol—Pipotiazine—ALB—ulcerative colitis	0.000571	0.0273	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—ulcerative colitis	0.000571	0.0273	CrCbGaD
Zuclopenthixol—Nausea—Budesonide—ulcerative colitis	0.00057	0.000761	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000568	0.000758	CcSEcCtD
Zuclopenthixol—Dizziness—Azathioprine—ulcerative colitis	0.000567	0.000756	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000563	0.000751	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000562	0.000749	CcSEcCtD
Zuclopenthixol—Asthenia—Mesalazine—ulcerative colitis	0.00056	0.000747	CcSEcCtD
Zuclopenthixol—Shock—Prednisolone—ulcerative colitis	0.000559	0.000746	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000555	0.000741	CcSEcCtD
Zuclopenthixol—Convulsion—Triamcinolone—ulcerative colitis	0.000555	0.00074	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisolone—ulcerative colitis	0.000555	0.00074	CcSEcCtD
Zuclopenthixol—Convulsion—Methylprednisolone—ulcerative colitis	0.000554	0.000739	CcSEcCtD
Zuclopenthixol—Hypertension—Triamcinolone—ulcerative colitis	0.000553	0.000738	CcSEcCtD
Zuclopenthixol—Pruritus—Mesalazine—ulcerative colitis	0.000552	0.000737	CcSEcCtD
Zuclopenthixol—Hypertension—Methylprednisolone—ulcerative colitis	0.000552	0.000736	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00055	0.000733	CcSEcCtD
Zuclopenthixol—Shock—Hydrocortisone—ulcerative colitis	0.000546	0.000729	CcSEcCtD
Zuclopenthixol—Myalgia—Triamcinolone—ulcerative colitis	0.000545	0.000727	CcSEcCtD
Zuclopenthixol—Vomiting—Azathioprine—ulcerative colitis	0.000545	0.000727	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000544	0.000726	CcSEcCtD
Zuclopenthixol—Myalgia—Methylprednisolone—ulcerative colitis	0.000544	0.000726	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—ulcerative colitis	0.000543	0.000725	CcSEcCtD
Zuclopenthixol—Anxiety—Methylprednisolone—ulcerative colitis	0.000542	0.000723	CcSEcCtD
Zuclopenthixol—Tachycardia—Hydrocortisone—ulcerative colitis	0.000542	0.000723	CcSEcCtD
Zuclopenthixol—Rash—Azathioprine—ulcerative colitis	0.00054	0.000721	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00054	0.000721	CcSEcCtD
Zuclopenthixol—Dermatitis—Azathioprine—ulcerative colitis	0.00054	0.00072	CcSEcCtD
Zuclopenthixol—Skin disorder—Hydrocortisone—ulcerative colitis	0.000539	0.000719	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000539	0.000719	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000539	0.000719	CcSEcCtD
Zuclopenthixol—Discomfort—Triamcinolone—ulcerative colitis	0.000539	0.000719	CcSEcCtD
Zuclopenthixol—Discomfort—Methylprednisolone—ulcerative colitis	0.000538	0.000717	CcSEcCtD
Zuclopenthixol—Headache—Azathioprine—ulcerative colitis	0.000537	0.000716	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000537	0.000716	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mesalazine—ulcerative colitis	0.000534	0.000713	CcSEcCtD
Zuclopenthixol—Dry mouth—Triamcinolone—ulcerative colitis	0.000533	0.000711	CcSEcCtD
Zuclopenthixol—Anorexia—Hydrocortisone—ulcerative colitis	0.000529	0.000706	CcSEcCtD
Zuclopenthixol—Angiopathy—Prednisone—ulcerative colitis	0.000528	0.000704	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—ulcerative colitis	0.000525	0.000701	CcSEcCtD
Zuclopenthixol—Malaise—Dexamethasone—ulcerative colitis	0.000524	0.000699	CcSEcCtD
Zuclopenthixol—Malaise—Betamethasone—ulcerative colitis	0.000524	0.000699	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000523	0.000697	CcSEcCtD
Zuclopenthixol—Vertigo—Dexamethasone—ulcerative colitis	0.000522	0.000697	CcSEcCtD
Zuclopenthixol—Vertigo—Betamethasone—ulcerative colitis	0.000522	0.000697	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000522	0.000696	CcSEcCtD
Zuclopenthixol—Syncope—Dexamethasone—ulcerative colitis	0.000521	0.000695	CcSEcCtD
Zuclopenthixol—Syncope—Betamethasone—ulcerative colitis	0.000521	0.000695	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—ulcerative colitis	0.000519	0.000693	CcSEcCtD
Zuclopenthixol—Hypotension—Hydrocortisone—ulcerative colitis	0.000519	0.000692	CcSEcCtD
Zuclopenthixol—Dizziness—Mesalazine—ulcerative colitis	0.000516	0.000689	CcSEcCtD
Zuclopenthixol—Shock—Triamcinolone—ulcerative colitis	0.000514	0.000686	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—ulcerative colitis	0.000514	0.000686	CcSEcCtD
Zuclopenthixol—Shock—Methylprednisolone—ulcerative colitis	0.000513	0.000685	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000512	0.000682	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000511	0.000681	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Betamethasone—ulcerative colitis	0.000511	0.000681	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisolone—ulcerative colitis	0.00051	0.000681	CcSEcCtD
Zuclopenthixol—Tachycardia—Triamcinolone—ulcerative colitis	0.00051	0.000681	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—ulcerative colitis	0.000509	0.00068	CcSEcCtD
Zuclopenthixol—Nausea—Azathioprine—ulcerative colitis	0.000509	0.000679	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—ulcerative colitis	0.000509	0.000679	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—ulcerative colitis	0.000507	0.000676	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—ulcerative colitis	0.000506	0.000675	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—ulcerative colitis	0.000506	0.000675	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000506	0.000675	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000505	0.000674	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000504	0.000673	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—ulcerative colitis	0.000504	0.000672	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—ulcerative colitis	0.000504	0.000672	CcSEcCtD
Zuclopenthixol—Insomnia—Hydrocortisone—ulcerative colitis	0.000502	0.00067	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—ulcerative colitis	0.000502	0.000669	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—ulcerative colitis	0.000502	0.000669	CcSEcCtD
Zuclopenthixol—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000499	0.000665	CcSEcCtD
Zuclopenthixol—Vomiting—Mesalazine—ulcerative colitis	0.000496	0.000662	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—ulcerative colitis	0.000495	0.00066	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—ulcerative colitis	0.000495	0.00066	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—ulcerative colitis	0.000493	0.000658	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—ulcerative colitis	0.000493	0.000658	CcSEcCtD
Zuclopenthixol—Rash—Mesalazine—ulcerative colitis	0.000492	0.000657	CcSEcCtD
Zuclopenthixol—Dermatitis—Mesalazine—ulcerative colitis	0.000492	0.000656	CcSEcCtD
Zuclopenthixol—Headache—Mesalazine—ulcerative colitis	0.000489	0.000652	CcSEcCtD
Zuclopenthixol—Discomfort—Dexamethasone—ulcerative colitis	0.000489	0.000652	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—ulcerative colitis	0.000489	0.000652	CcSEcCtD
Zuclopenthixol—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000489	0.000652	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—ulcerative colitis	0.000487	0.00065	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—ulcerative colitis	0.000486	0.000648	CcSEcCtD
Zuclopenthixol—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000483	0.000644	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000479	0.000639	CcSEcCtD
Zuclopenthixol—Fatigue—Hydrocortisone—ulcerative colitis	0.000479	0.000639	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—ulcerative colitis	0.000477	0.000636	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000476	0.000635	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000475	0.000634	CcSEcCtD
Zuclopenthixol—Pain—Hydrocortisone—ulcerative colitis	0.000475	0.000633	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000474	0.000633	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000474	0.000633	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—ulcerative colitis	0.000473	0.000631	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—ulcerative colitis	0.000472	0.000629	CcSEcCtD
Zuclopenthixol—Fluphenazine—ABCB1—ulcerative colitis	0.000471	0.0225	CrCbGaD
Zuclopenthixol—Ill-defined disorder—Prednisone—ulcerative colitis	0.00047	0.000626	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—ulcerative colitis	0.000469	0.000626	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—ulcerative colitis	0.000468	0.000625	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000468	0.000625	CcSEcCtD
Zuclopenthixol—Shock—Dexamethasone—ulcerative colitis	0.000467	0.000623	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—ulcerative colitis	0.000467	0.000623	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—ulcerative colitis	0.000466	0.000622	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000465	0.000621	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—ulcerative colitis	0.000465	0.000621	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—ulcerative colitis	0.000465	0.000621	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000464	0.00062	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000464	0.00062	CcSEcCtD
Zuclopenthixol—Nausea—Mesalazine—ulcerative colitis	0.000464	0.000619	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—ulcerative colitis	0.000463	0.000618	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—ulcerative colitis	0.000463	0.000618	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—ulcerative colitis	0.00046	0.000614	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000459	0.000613	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000459	0.000612	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000459	0.000612	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000458	0.00061	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—ulcerative colitis	0.000456	0.000609	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—ulcerative colitis	0.000455	0.000607	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000454	0.000606	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—ulcerative colitis	0.000454	0.000606	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—ulcerative colitis	0.000452	0.000603	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—ulcerative colitis	0.000452	0.000603	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—ulcerative colitis	0.000451	0.000601	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—ulcerative colitis	0.00045	0.0006	CcSEcCtD
Zuclopenthixol—Pain—Triamcinolone—ulcerative colitis	0.000447	0.000596	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—ulcerative colitis	0.000445	0.000593	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—ulcerative colitis	0.000443	0.000591	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—ulcerative colitis	0.000443	0.000591	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000439	0.000585	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000439	0.000585	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—ulcerative colitis	0.000439	0.000585	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—ulcerative colitis	0.000437	0.000583	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000432	0.000577	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000432	0.000577	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—ulcerative colitis	0.000431	0.000575	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000431	0.000575	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00043	0.000573	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—ulcerative colitis	0.000429	0.000573	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—ulcerative colitis	0.000429	0.000572	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—ulcerative colitis	0.000429	0.000572	CcSEcCtD
Zuclopenthixol—Chlorprothixene—ABCB1—ulcerative colitis	0.000429	0.0205	CrCbGaD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000428	0.000571	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000427	0.000569	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—ulcerative colitis	0.000426	0.000568	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—ulcerative colitis	0.000426	0.000568	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—ulcerative colitis	0.000426	0.000568	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—ulcerative colitis	0.000419	0.000559	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—ulcerative colitis	0.000418	0.000557	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—ulcerative colitis	0.000418	0.000557	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—ulcerative colitis	0.000413	0.000551	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—ulcerative colitis	0.000413	0.000551	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000412	0.00055	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—ulcerative colitis	0.000412	0.00055	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—ulcerative colitis	0.000412	0.00055	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00041	0.000546	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00041	0.000546	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000409	0.000546	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—ulcerative colitis	0.000409	0.000546	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—ulcerative colitis	0.000409	0.000546	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—ulcerative colitis	0.000406	0.000542	CcSEcCtD
Zuclopenthixol—Pain—Dexamethasone—ulcerative colitis	0.000406	0.000541	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—ulcerative colitis	0.000406	0.000541	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—ulcerative colitis	0.000405	0.00054	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—ulcerative colitis	0.000403	0.000538	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—ulcerative colitis	0.000401	0.000535	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—ulcerative colitis	0.000399	0.000533	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrocortisone—ulcerative colitis	0.000398	0.000531	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—ulcerative colitis	0.000394	0.000525	CcSEcCtD
Zuclopenthixol—Pruritus—Hydrocortisone—ulcerative colitis	0.000393	0.000524	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000391	0.000521	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—ulcerative colitis	0.000391	0.000521	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000388	0.000517	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000388	0.000517	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000385	0.000514	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000384	0.000513	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00038	0.000507	CcSEcCtD
Zuclopenthixol—Trifluoperazine—ABCB1—ulcerative colitis	0.000376	0.018	CrCbGaD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000376	0.000502	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—ulcerative colitis	0.000376	0.000501	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—ulcerative colitis	0.000375	0.0005	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—ulcerative colitis	0.000375	0.0005	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—ulcerative colitis	0.000375	0.0005	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—ulcerative colitis	0.000375	0.0005	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—ulcerative colitis	0.000375	0.0005	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—ulcerative colitis	0.000374	0.000499	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—ulcerative colitis	0.000374	0.000498	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—ulcerative colitis	0.000371	0.000495	CcSEcCtD
Zuclopenthixol—Pruritus—Triamcinolone—ulcerative colitis	0.00037	0.000493	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—ulcerative colitis	0.000369	0.000492	CcSEcCtD
Zuclopenthixol—Dizziness—Hydrocortisone—ulcerative colitis	0.000367	0.00049	CcSEcCtD
Zuclopenthixol—Quetiapine—ABCB1—ulcerative colitis	0.000365	0.0174	CrCbGaD
Zuclopenthixol—Dyspepsia—Prednisone—ulcerative colitis	0.000364	0.000485	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—ulcerative colitis	0.000359	0.000479	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—ulcerative colitis	0.000358	0.000478	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—ulcerative colitis	0.000358	0.000478	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000357	0.000476	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—ulcerative colitis	0.000356	0.000475	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—ulcerative colitis	0.000356	0.000475	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—ulcerative colitis	0.000353	0.000471	CcSEcCtD
Zuclopenthixol—Vomiting—Hydrocortisone—ulcerative colitis	0.000353	0.000471	CcSEcCtD
Zuclopenthixol—Rash—Hydrocortisone—ulcerative colitis	0.00035	0.000467	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrocortisone—ulcerative colitis	0.00035	0.000467	CcSEcCtD
Zuclopenthixol—Headache—Hydrocortisone—ulcerative colitis	0.000348	0.000464	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—ulcerative colitis	0.000346	0.000461	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—ulcerative colitis	0.000345	0.00046	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—ulcerative colitis	0.00034	0.000454	CcSEcCtD
Zuclopenthixol—Asthenia—Dexamethasone—ulcerative colitis	0.00034	0.000454	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—ulcerative colitis	0.00034	0.000454	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000338	0.000451	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—ulcerative colitis	0.000338	0.00045	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—ulcerative colitis	0.000336	0.000448	CcSEcCtD
Zuclopenthixol—Pruritus—Betamethasone—ulcerative colitis	0.000336	0.000448	CcSEcCtD
Zuclopenthixol—Vomiting—Triamcinolone—ulcerative colitis	0.000332	0.000443	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—ulcerative colitis	0.000332	0.000442	CcSEcCtD
Zuclopenthixol—Nausea—Hydrocortisone—ulcerative colitis	0.00033	0.00044	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—ulcerative colitis	0.00033	0.00044	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—ulcerative colitis	0.000329	0.000439	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—ulcerative colitis	0.000329	0.000439	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—ulcerative colitis	0.000329	0.000438	CcSEcCtD
Zuclopenthixol—Headache—Triamcinolone—ulcerative colitis	0.000328	0.000437	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—ulcerative colitis	0.000327	0.000436	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—ulcerative colitis	0.000327	0.000436	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—ulcerative colitis	0.000327	0.000436	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dexamethasone—ulcerative colitis	0.000325	0.000433	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—ulcerative colitis	0.000325	0.000433	CcSEcCtD
Zuclopenthixol—Clozapine—ABCB1—ulcerative colitis	0.000314	0.015	CrCbGaD
Zuclopenthixol—Dizziness—Dexamethasone—ulcerative colitis	0.000314	0.000418	CcSEcCtD
Zuclopenthixol—Dizziness—Betamethasone—ulcerative colitis	0.000314	0.000418	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—ulcerative colitis	0.000311	0.000414	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—ulcerative colitis	0.00031	0.000413	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ALB—ulcerative colitis	0.00031	0.0148	CrCbGaD
Zuclopenthixol—Hypersensitivity—Prednisone—ulcerative colitis	0.000304	0.000406	CcSEcCtD
Zuclopenthixol—Vomiting—Betamethasone—ulcerative colitis	0.000302	0.000402	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—ulcerative colitis	0.000302	0.000402	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—ulcerative colitis	0.000299	0.000399	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—ulcerative colitis	0.000299	0.000399	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—ulcerative colitis	0.000299	0.000399	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—ulcerative colitis	0.000299	0.000399	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—ulcerative colitis	0.000297	0.000396	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—ulcerative colitis	0.000297	0.000396	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—ulcerative colitis	0.000296	0.000395	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ABCB1—ulcerative colitis	0.000295	0.0141	CrCbGaD
Zuclopenthixol—Pruritus—Prednisone—ulcerative colitis	0.000292	0.00039	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—ulcerative colitis	0.000283	0.000377	CcSEcCtD
Zuclopenthixol—Nausea—Dexamethasone—ulcerative colitis	0.000282	0.000376	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—ulcerative colitis	0.000282	0.000376	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—ulcerative colitis	0.000273	0.000364	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—ulcerative colitis	0.000263	0.00035	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—ulcerative colitis	0.00026	0.000347	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—ulcerative colitis	0.00026	0.000347	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—ulcerative colitis	0.000259	0.000345	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—ulcerative colitis	0.000245	0.000327	CcSEcCtD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADRB2—ulcerative colitis	8.97e-05	0.000504	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—TP53—ulcerative colitis	8.96e-05	0.000503	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	8.93e-05	0.000502	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CALM3—ulcerative colitis	8.82e-05	0.000495	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	8.8e-05	0.000494	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CXCL8—ulcerative colitis	8.79e-05	0.000494	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL20—ulcerative colitis	8.76e-05	0.000492	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—JAK2—ulcerative colitis	8.75e-05	0.000491	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RIPK2—ulcerative colitis	8.69e-05	0.000488	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	8.69e-05	0.000488	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	8.62e-05	0.000484	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL20—ulcerative colitis	8.6e-05	0.000483	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTGER4—ulcerative colitis	8.56e-05	0.000481	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	8.44e-05	0.000474	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—IL2—ulcerative colitis	8.4e-05	0.000472	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADRB2—ulcerative colitis	8.29e-05	0.000466	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADCY5—ulcerative colitis	8.29e-05	0.000466	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GNA12—ulcerative colitis	8.24e-05	0.000463	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—IL6—ulcerative colitis	8.21e-05	0.000461	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	8.18e-05	0.000459	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	8.16e-05	0.000458	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADRB2—ulcerative colitis	8.14e-05	0.000457	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	8.11e-05	0.000455	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GNA12—ulcerative colitis	8.09e-05	0.000454	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	7.99e-05	0.000449	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CXCL8—ulcerative colitis	7.98e-05	0.000448	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	7.94e-05	0.000446	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	7.84e-05	0.00044	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GHRL—ulcerative colitis	7.84e-05	0.00044	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCR2—ulcerative colitis	7.81e-05	0.000439	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CXCL8—ulcerative colitis	7.81e-05	0.000438	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—ADCY5—ulcerative colitis	7.75e-05	0.000435	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	7.68e-05	0.000432	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	7.68e-05	0.000431	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCR2—ulcerative colitis	7.67e-05	0.000431	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CXCL8—ulcerative colitis	7.66e-05	0.00043	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.65e-05	0.00043	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.63e-05	0.000429	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL2—ulcerative colitis	7.63e-05	0.000429	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	7.63e-05	0.000428	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADCY5—ulcerative colitis	7.61e-05	0.000427	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CALM3—ulcerative colitis	7.59e-05	0.000426	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADRB2—ulcerative colitis	7.54e-05	0.000423	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	7.52e-05	0.000423	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	7.52e-05	0.000422	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.49e-05	0.000421	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RIPK2—ulcerative colitis	7.48e-05	0.00042	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	7.47e-05	0.000419	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—JAK2—ulcerative colitis	7.44e-05	0.000418	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	7.42e-05	0.000417	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	7.37e-05	0.000414	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—ALB—ulcerative colitis	7.36e-05	0.000414	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR6—ulcerative colitis	7.34e-05	0.000412	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	7.22e-05	0.000406	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR6—ulcerative colitis	7.21e-05	0.000405	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	7.07e-05	0.000397	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADCY5—ulcerative colitis	7.04e-05	0.000395	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	6.99e-05	0.000393	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	6.99e-05	0.000392	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAML2—ulcerative colitis	6.96e-05	0.000391	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	6.94e-05	0.00039	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	6.93e-05	0.000389	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADCY5—ulcerative colitis	6.91e-05	0.000388	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	6.85e-05	0.000385	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—JAK2—ulcerative colitis	6.85e-05	0.000384	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAML2—ulcerative colitis	6.83e-05	0.000384	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS1—ulcerative colitis	6.82e-05	0.000383	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CXCL8—ulcerative colitis	6.79e-05	0.000381	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	6.78e-05	0.000381	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—JAK2—ulcerative colitis	6.75e-05	0.000379	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	6.71e-05	0.000377	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	6.57e-05	0.000369	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADRB2—ulcerative colitis	6.49e-05	0.000364	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2—ulcerative colitis	6.49e-05	0.000364	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTGER4—ulcerative colitis	6.46e-05	0.000363	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—JAK2—ulcerative colitis	6.4e-05	0.000359	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADCY5—ulcerative colitis	6.4e-05	0.000359	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	6.36e-05	0.000357	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTGER4—ulcerative colitis	6.35e-05	0.000356	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	6.3e-05	0.000354	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	6.23e-05	0.00035	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	6.23e-05	0.00035	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CXCL8—ulcerative colitis	6.16e-05	0.000346	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CALM3—ulcerative colitis	6.14e-05	0.000345	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2—ulcerative colitis	5.97e-05	0.000335	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GHRL—ulcerative colitis	5.92e-05	0.000332	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2—ulcerative colitis	5.89e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	5.84e-05	0.000328	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	5.82e-05	0.000327	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—JAK2—ulcerative colitis	5.81e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GHRL—ulcerative colitis	5.81e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	5.79e-05	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CALM3—ulcerative colitis	5.73e-05	0.000322	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	5.7e-05	0.00032	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RIPK2—ulcerative colitis	5.65e-05	0.000317	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	5.64e-05	0.000317	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CALM3—ulcerative colitis	5.63e-05	0.000316	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—ulcerative colitis	5.58e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	5.56e-05	0.000312	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RIPK2—ulcerative colitis	5.54e-05	0.000311	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	5.52e-05	0.00031	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADCY5—ulcerative colitis	5.51e-05	0.000309	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	5.44e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCL8—ulcerative colitis	5.31e-05	0.000298	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	5.3e-05	0.000298	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—JAK2—ulcerative colitis	5.17e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	5.13e-05	0.000288	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—ulcerative colitis	5.07e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	5.05e-05	0.000284	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RELA—ulcerative colitis	5.01e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	4.9e-05	0.000275	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	4.83e-05	0.000271	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	4.82e-05	0.000271	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB2—ulcerative colitis	4.81e-05	0.00027	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ABCB1—ulcerative colitis	4.77e-05	0.000268	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	4.76e-05	0.000267	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—JAK2—ulcerative colitis	4.75e-05	0.000266	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	4.72e-05	0.000265	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL8—ulcerative colitis	4.72e-05	0.000265	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	4.66e-05	0.000262	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	4.66e-05	0.000261	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—ulcerative colitis	4.51e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—ulcerative colitis	4.49e-05	0.000252	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ADCY5—ulcerative colitis	4.45e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.44e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.41e-05	0.000248	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	4.39e-05	0.000246	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	4.39e-05	0.000246	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	4.34e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL8—ulcerative colitis	4.33e-05	0.000243	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	4.33e-05	0.000243	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	4.32e-05	0.000243	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—JAK2—ulcerative colitis	4.31e-05	0.000242	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MMP9—ulcerative colitis	4.27e-05	0.00024	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	4.25e-05	0.000239	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	4.23e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NFKB1—ulcerative colitis	4.22e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	4.22e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	4.16e-05	0.000234	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	4.15e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—ulcerative colitis	4.14e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	4.09e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADCY5—ulcerative colitis	4.08e-05	0.000229	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	4.06e-05	0.000228	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	4.01e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	4.01e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CALM3—ulcerative colitis	4e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—JAK2—ulcerative colitis	3.99e-05	0.000224	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.95e-05	0.000222	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	3.94e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	3.93e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	3.93e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RELA—ulcerative colitis	3.86e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	3.86e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—ulcerative colitis	3.83e-05	0.000215	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—ulcerative colitis	3.83e-05	0.000215	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—STAT3—ulcerative colitis	3.79e-05	0.000213	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	3.77e-05	0.000212	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	3.77e-05	0.000212	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—ulcerative colitis	3.76e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	3.72e-05	0.000209	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	3.69e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL8—ulcerative colitis	3.64e-05	0.000204	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	3.59e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—ulcerative colitis	3.52e-05	0.000197	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—ulcerative colitis	3.48e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—ulcerative colitis	3.46e-05	0.000194	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—JAK2—ulcerative colitis	3.43e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	3.43e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RELA—ulcerative colitis	3.33e-05	0.000187	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARG—ulcerative colitis	3.32e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—ulcerative colitis	3.29e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	3.26e-05	0.000183	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	3.13e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.11e-05	0.000175	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—ulcerative colitis	3e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—ulcerative colitis	2.99e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—ulcerative colitis	2.98e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—ulcerative colitis	2.93e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.9e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—ulcerative colitis	2.89e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—ulcerative colitis	2.83e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	2.8e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	2.71e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—ulcerative colitis	2.65e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—ulcerative colitis	2.61e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—JAK2—ulcerative colitis	2.59e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	2.55e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—JAK2—ulcerative colitis	2.55e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—ulcerative colitis	2.52e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RELA—ulcerative colitis	2.51e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	2.5e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RELA—ulcerative colitis	2.47e-05	0.000139	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RELA—ulcerative colitis	2.47e-05	0.000138	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	2.42e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	2.37e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	2.34e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	2.33e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	2.32e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	2.32e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	2.28e-05	0.000128	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—ulcerative colitis	2.26e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—ulcerative colitis	2.25e-05	0.000126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	2.25e-05	0.000126	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—ulcerative colitis	2.23e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—ulcerative colitis	2.23e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—ulcerative colitis	2.22e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	2.21e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—ulcerative colitis	2.21e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	2.18e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	2.17e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.16e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—ulcerative colitis	2.14e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	2.12e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	2.12e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	2.11e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—ulcerative colitis	2.1e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	2.08e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	2.08e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	2.06e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—ulcerative colitis	2.05e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	2.04e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	2.02e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	2.01e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—ulcerative colitis	1.95e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—ulcerative colitis	1.92e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	1.92e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—ulcerative colitis	1.9e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	1.9e-05	0.000106	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	1.87e-05	0.000105	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—ulcerative colitis	1.87e-05	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	1.83e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	1.76e-05	9.91e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—ulcerative colitis	1.76e-05	9.89e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	1.74e-05	9.75e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	1.73e-05	9.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	1.7e-05	9.57e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.7e-05	9.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	1.7e-05	9.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	1.58e-05	8.87e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—ulcerative colitis	1.45e-05	8.15e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—ulcerative colitis	1.43e-05	8.02e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—ulcerative colitis	1.43e-05	8.01e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	1.4e-05	7.86e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—ulcerative colitis	1.33e-05	7.46e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—ulcerative colitis	1.31e-05	7.34e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—ulcerative colitis	1.31e-05	7.33e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	1.3e-05	7.3e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	1.28e-05	7.19e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	1.19e-05	6.68e-05	CbGpPWpGaD
